Most Recent
Treasurer blocks Cosette’s $672M takeover of Mayne Pharma
Treasurer Jim Chalmers has blocked Cosette's $672 million takeover of Mayne Pharma on national interest grounds after the US drug maker threatened to close a critical drug facility in Adelaide.
Takeovers Panel says Cosette can’t shutter Mayne’s Adelaide drug plant
The Takeovers Panel has found Cosette cannot close a Mayne Pharma drug manufacturing plant in Adelaide, another win for Mayne in its push to block the US drug maker from walking away from their $672 million merger.
Optus fined $826,000 over scam breaches
Optus has been hit with a penalty of more than $826,000 after scammers exploited a vulnerability in its third-party verification system and stole $39,000 from customers' bank accounts.
Mayne wins extension of FIRB deadline for Cosette takeover
The Foreign Investment Review Board has extended the deadline for ruling on Cosette's proposed $672 million takeover of Mayne Pharma.
Mayne, Cosette row to be decided on merits after panel resets merger clock
The Takeovers Panel has agreed to hear Mayne Pharma's latest dispute with Cosette over the US drug maker's attempts to walk away from their $672 million merger agreement and extended the timeline for completing the deal.
Court approves $8.7M settlement in Exactech class action
A judge has approved a "modest" $8.7 million settlement in a class action against medical device maker Exactech over allegedly defective joint replacements, saying the settlement was fair and reasonable given the limited assets of the company, whose parent has filed for bankruptcy in the US.
Mayne wins breathing room in fight to get Cosette merger over the line
Mayne Pharma has secured an extension of the deadline for securing Foreign Investment Review Board approval of its $672 million tie-up with US drug maker Cosette.
Cosette appeals loss over exit from $672M Mayne Pharma merger
Cosette plans to appeal a ruling that rejected its bid to terminate an agreement to merge with Mayne Pharma, as the US drug company also refuses to agree to conditions needed to win Foreign Investment Review Board approval for the tie-up.
Mayne turns to Takeovers Panel in latest move to salvage $672M Cosette deal
Mayne Pharma is not walking away from US drug maker Cosette's proposed takeover without a fight, filing an application with the Takeovers Panel to force Cosette to agree to the conditions needed to win FIRB approval for the $672 million deal.
IVF provider Genea to face representative complaint over data breach
A class action law firm is set to file a representative complaint against fertility services provider Genea over a data breach that led to sensitive patient information being published on the dark web.